Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative bulk and single-cell analyses implicate ASL in MIF-associated myeloid programs in glioblastoma.

Functional & integrative genomics·2026
Same author

Designing a carbon-encapsulated ZnS/SnS<sub>2</sub>/SnO<sub>2</sub> heterojunction secondary battery anode displaying large capacity and good stability.

Nanoscale·2026
Same author

Mass spectrometry-based proteome atlas of the Brassica napus L.

The Plant journal : for cell and molecular biology·2026
Same author

Orchestrating immunity and beyond: polysaccharides as multi-target regulators of inflammatory networks via gut microbiota and structure-dependent pathways.

Food research international (Ottawa, Ont.)·2026
Same author

A novel oncolytic herpes simplex virus type 2 induces polarization of tumor-associated macrophages and remodels the immune microenvironment in glioblastoma.

Cancer immunology, immunotherapy : CII·2026
Same author

microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3.

Nature communications·2026

Related Experiment Video

Updated: Mar 9, 2026

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.1K

Human neural progenitors derived from integration-free iPSCs for SCI therapy.

Ying Liu1, Yiyan Zheng2, Shenglan Li2

  • 1Department of Neurosurgery, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA; The Senator Lloyd & B.A. Bentsen Center for Stroke Research, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA.

Stem Cell Research
|January 11, 2017
PubMed
Summary

This study presents a novel pipeline for generating neural progenitor cells (NPCs) from patient urine-derived induced pluripotent stem cells (iPSCs) for spinal cord injury (SCI) treatment. The method ensures safe cell sourcing, reprogramming, and purification, advancing potential clinical applications.

Keywords:
Neural repairNeuroprotectionSpinal cord injuryiPSC

More Related Videos

Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells
10:16

Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells

Published on: June 14, 2017

7.8K
Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

13.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.1K
Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells
10:16

Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells

Published on: June 14, 2017

7.8K
Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

13.0K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Neuroscience

Background:

  • Induced pluripotent stem cells (iPSCs) offer a promising autologous source for tissue regeneration in spinal cord injury (SCI).
  • Clinical translation of iPSC-derived neural progenitor cells (NPCs) faces challenges including cell source accessibility, safe reprogramming, and purification.

Purpose of the Study:

  • To develop a safe, cost-effective, and clinically relevant pipeline for generating patient-specific NPCs for SCI.
  • To address critical hurdles in cell sourcing, reprogramming, differentiation, and purification for iPSC-based SCI therapy.

Main Methods:

  • Urine-derived cells were reprogrammed into iPSCs using non-integrating Sendai viral vectors.
  • Neural differentiation protocols were optimized, and NPCs were purified using A2B5 antibody via fluorescence-activated cell sorting.
  • Purified NPCs were transplanted into a contused mouse thoracic spinal cord model.

Main Results:

  • The pipeline successfully generated clinically relevant NPCs from patient urine.
  • Transplanted A2B5+ NPCs survived, integrated into the injured spinal cord, and differentiated into neurons and glia.
  • The method addresses timing and safety concerns for iPSC-based SCI transplantation.

Conclusions:

  • This study provides a validated pipeline for generating patient-specific NPCs for SCI treatment.
  • The developed method enhances the safety and efficiency of iPSC-derived cell therapy for spinal cord regeneration.
  • This work represents a significant step towards clinical application of human iPSC derivatives in SCI settings.